Furthermore, C1QTNF1-AS1 has been linked to poor prognosis in cervical cancer patients [77] and has also been found to be one of the most abundantly altered genes in triple negative breast cancer cells in response to DOX treatment [78]. The gene discussed is C1QTNF1; the disease is cervical carcinoma.